CASTLE BIOSCIENCES INC (CSTL) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — CSTL

Balance Sheet

(in millions USD)

Metric	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022	Q3 2021	Q2 2021	Q1 2021
Cash & Equivalents	63.76	85.56	82.23	89.69	94.96	85.57	82.95	91.22	95.87	114.82	134.18	273.17	309.02	363.18	368.34	406.98
Short-term Investments	197.92	201.99	193.70	185.46	--	--	--	--	--	--	--	--	--	--	--	--
Accounts Receivable	42.26	49.48	52.31	56.35	50.26	45.99	42.70	37.00	31.31	27.73	22.84	22.61	19.91	18.53	17.82	14.29
Inventory	10.46	8.65	8.37	6.85	6.57	8.01	7.65	5.77	6.12	4.52	3.80	3.37	2.35	2.38	2.12	2.31
Total Current Assets	328.90	357.57	348.67	349.39	344.77	320.40	295.78	279.62	269.05	271.10	299.41	304.91	336.44	389.58	391.70	426.67
Property, Plant & Equipment	100.93	84.89	74.06	55.42	44.38	38.64	32.90	22.27	20.51	18.25	13.05	11.20	9.39	8.87	8.09	7.78
Goodwill	10.70	10.70	10.70	10.70	10.70	10.70	10.70	10.70	10.70	10.70	10.49	10.49	--	--	--	--
Intangible Assets	86.66	91.16	93.43	67.21	99.88	102.15	104.40	108.92	111.19	113.43	119.87	122.18	87.28	32.10	32.80	--
Total Non-current Assets*	218.90	205.22	196.06	152.33	169.79	166.91	162.73	156.40	156.35	155.79	158.40	153.47	107.98	44.11	43.83	10.66
Total Assets	547.80	562.79	544.73	501.72	514.57	487.31	458.51	436.02	425.40	426.89	457.81	458.38	444.43	433.69	435.53	437.33
Accounts Payable	15.04	12.21	13.18	8.50	6.81	9.54	9.32	6.93	7.14	9.96	5.77	3.28	3.31	2.77	1.37	2.17
Total Current Liabilities	48.76	55.31	50.89	37.27	44.30	39.45	31.96	36.32	33.72	30.14	31.94	27.52	39.52	20.99	18.65	17.58
Long-term Debt	10.07	10.05	10.04	10.03	10.02	10.01	10.00	--	--	--	--	--	--	--	--	--
Total Non-current Liabilities*	37.63	40.43	38.46	24.14	29.22	23.97	24.09	13.91	12.92	11.60	14.44	9.20	7.57	0.99	0.96	1.17
Total Liabilities	86.39	95.74	89.35	61.41	73.51	63.42	56.05	50.24	46.63	41.74	46.38	36.72	47.09	21.98	19.62	18.75
Retained Earnings	(238.81)	(221.95)	(221.45)	(225.97)	(209.72)	(211.98)	(220.90)	(215.79)	(208.89)	(190.11)	(140.29)	(120.04)	(118.39)	(87.36)	(75.57)	(66.78)
Total Stockholder Equity	461.42	467.05	455.38	440.31	441.06	423.89	402.46	385.78	378.77	385.15	411.43	421.66	397.34	411.71	415.92	418.59

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Total Revenue	83.68	87.01	83.04	86.19	87.99	86.31	85.78	87.00	72.97	66.12	61.49	50.14	42.04	38.34	37.01	34.84	26.85	25.04	23.48	22.76
Cost of Revenue*	20.53	18.32	18.70	17.63	16.38	16.18	15.61	14.52	13.89	12.42	11.32	11.06	10.18	9.52	8.86	7.69	5.94	4.60	4.50	3.70
Gross Profit*	63.15	68.69	64.34	68.56	71.61	70.13	70.17	72.48	59.08	53.70	50.17	39.08	31.86	28.82	28.15	27.15	20.91	20.44	18.98	19.06
Research & Development	14.43	13.52	12.96	12.79	12.59	11.77	12.32	14.14	13.81	12.99	12.92	13.31	14.39	11.31	10.91	11.93	10.76	9.45	7.50	6.79
Selling, General & Admin	64.90	56.73	55.91	58.07	58.62	49.97	50.50	51.09	48.50	44.09	44.62	44.68	46.76	38.43	36.63	37.50	30.45	25.16	22.60	20.82
Total Operating Expenses*	81.55	72.52	71.14	72.81	99.53	66.08	65.09	67.47	64.55	59.36	59.81	60.24	63.38	51.65	49.69	31.12	45.42	35.61	30.79	27.87
Operating Income	(18.41)	(3.83)	(6.80)	(4.25)	(27.93)	4.05	5.08	5.01	(5.47)	(5.66)	(9.64)	(21.16)	(31.52)	(22.83)	(21.54)	(3.97)	(24.52)	(15.17)	(11.81)	(8.81)
Interest Expense	--	--	--	0.01	0.01	--	0.19	0.22	0.01	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00
Pretax Income*	(14.41)	(2.71)	(0.39)	(0.14)	(26.27)	7.89	8.28	7.89	(2.49)	(2.54)	(6.87)	(18.76)	(29.19)	(20.56)	(20.25)	(3.60)	(24.49)	(15.15)	(11.79)	(8.79)
Tax Provision	0.11	(0.38)	0.12	(4.67)	(0.42)	(1.70)	6.01	(1.03)	0.05	0.04	0.03	0.02	0.01	0.06	0.00	(1.96)	0.13	(8.72)	0.00	0.01
Net Income	(14.52)	(2.33)	(0.50)	4.52	(25.85)	9.59	2.27	8.92	(2.53)	(2.58)	(6.90)	(18.78)	(29.20)	(20.62)	(20.25)	(1.65)	(24.62)	(6.43)	(11.79)	(8.79)
Basic EPS	(0.49)	(0.07)	(0.02)	0.16	(0.90)	0.35	0.08	0.32	(0.09)	(0.08)	(0.26)	(0.70)	(1.10)	(0.78)	(0.77)	(0.06)	(0.97)	(0.25)	(0.47)	(0.35)
Diluted EPS	(0.49)	(0.06)	(0.02)	0.15	(0.90)	0.32	0.08	0.31	(0.09)	(0.08)	(0.26)	(0.70)	(1.10)	(0.78)	(0.77)	(0.06)	(0.97)	(0.25)	(0.47)	(0.35)

* Derived from reported values

Cash Flow Statement

(in millions USD)

Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Operating Cash Flow	(22.13)	26.93	22.63	20.82	(6.04)	24.37	23.34	24.00	(6.83)	18.59	5.01	(3.79)	(25.44)	(6.00)	(5.22)	(9.00)	(21.43)	(2.78)	(6.13)	(6.44)
Capital Expenditures	12.46	7.18	14.83	9.26	4.74	7.57	6.38	5.23	9.15	3.79	2.46	4.04	3.34	1.79	2.04	1.41	0.40	0.89	0.93	0.91
Free Cash Flow*	(34.58)	19.75	7.80	11.56	(10.78)	16.80	16.96	18.77	(15.99)	14.79	2.56	(7.82)	(28.78)	(7.79)	(7.26)	(10.41)	(21.83)	(3.67)	(7.06)	(7.35)
Investing Cash Flow	(25.80)	8.83	(18.39)	(28.38)	(22.43)	5.77	(14.79)	(21.42)	(19.70)	(7.67)	(9.71)	(15.39)	16.58	(4.48)	(134.15)	(27.51)	(0.40)	(30.89)	(0.92)	(34.09)
Financing Cash Flow	(5.03)	(4.59)	(0.92)	0.10	(1.55)	(5.38)	0.84	0.04	10.64	(3.30)	0.05	0.23	0.73	(0.75)	0.39	0.66	1.22	0.13	1.89	1.89

* Derived from reported values